 | Tarsus Pharmaceuticals, Inc. | |||
| NMS : TARS || Location: United States | ||||
$31.75-0.46 (-1.43%) |
0.04 M | 31.75 - 33.21 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 7.900 M |
| March 28, 2024 | 7.850 M |
| March 15, 2024 | 7.195 M |
| Feb. 29, 2024 | 6.032 M |
| Feb. 15, 2024 | 5.663 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -1.39 | -1.31 | 5.75% |
| 09/30/2023 | -1.39 | -1.28 | 8.10% |
| 06/30/2023 | -1.10 | -1.17 | -6.35% |
| 03/31/2023 | -0.96 | -0.88 | 8.70% |
| 12/31/2022 | -0.70 | -0.49 | 30.38% |
TARS Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 37.500M | Shares Float | 24.386M |
| Short Float | 7.900M | Market Cap | 1207.88M |
| Institution ownership | 87.97% | Insider ownership | 4.265% |
| Earnings Date | 05/07/2024 AMC | Cash Per Share | ? |
| Trailing EPS | -4.62 | Forward EPS | -1.88 |